etoposide has been researched along with Orphan Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
| Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J | 1 |
| Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A | 1 |
| Junga, Z; Keith, M; Stitt, R; Tracy, C | 1 |
| Bar-Sela, G; Miller, RC; Novotny, PJ; Sio, TT; Sohawon, S; Thariat, J; Van Houtte, P; Vu, CC | 1 |
| Cai, L; Du, J; Li, W; Ma, X; Zhang, J | 1 |
| Fung, MA; Ho, B; Kiuru, M; Millsop, JW; Sharon, VR | 1 |
| Alvarez, MJ; Ambesi-Impiombato, A; Andrews, SJ; Califano, A; Dela Cruz, FS; Diolaiti, D; Forouhar, F; Glade Bender, JL; Kung, AL; Mansukhani, MM; Marks, LJ; Mitchell, CM; Modzelewski, B; Nagy, PL; Rainey, AR; Turk, AT; Yamashiro, DJ | 1 |
| Chamberlain, MC; Glantz, MJ | 1 |
| Fukushima, T; Kumagai, M; Shichino, H | 1 |
| Biesma, DH; Grutters, JC; Post, MC; Verzijlbergen, JF | 1 |
1 review(s) available for etoposide and Orphan Diseases
| Article | Year |
|---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
10 other study(ies) available for etoposide and Orphan Diseases
| Article | Year |
|---|---|
Hemophagocytic relapsed intramedullary plasmacytoma.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome | 2020 |
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult | 2020 |
Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Topics: Antineoplastic Agents, Immunological; Antirheumatic Agents; Diagnosis, Differential; Etoposide; Female; Humans; Hydroxychloroquine; Infusions, Intravenous; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Rare Diseases; Rituximab; Treatment Outcome; Young Adult | 2017 |
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Lower Extremity; Male; Methotrexate; Middle Aged; Mitomycin; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radiotherapy; Rare Diseases; Retroperitoneal Neoplasms; Retrospective Studies; Soft Tissue Neoplasms; Tumor Burden; Young Adult | 2016 |
A case of an adult Langerhans cell sarcoma.
Topics: Biopsy, Needle; Disease Progression; Drug Therapy, Combination; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Langerhans Cell Sarcoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nose; Positron-Emission Tomography; Prednisone; Rare Diseases; Risk Assessment; Skin Neoplasms; Vincristine | 2016 |
Cutaneous Hemophagocytic Lymphohistiocytosis: Bean Bags From the Bone.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Dexamethasone; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Rare Diseases; Risk Assessment; Severity of Illness Index; Skin Neoplasms; Treatment Outcome | 2016 |
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; DNA Mutational Analysis; Etoposide; Fatal Outcome; Genomics; Humans; Male; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Paclitaxel; Rare Diseases; Scalp; Xenograft Model Antitumor Assays | 2016 |
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2008 |
[Neuroblastoma trial to overcome a rare malignant disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Neuroblastoma; Rare Diseases; Transplantation, Autologous | 2007 |
PET scintigraphy of etoposide-induced pulmonary toxicity.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Fluorodeoxyglucose F18; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases; Male; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases | 2007 |